| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.4M | +304.0% |
| R&D Expense | $182K | -41.6% |
| SG&A Expense | $11.4M | +57.2% |
| Operating Income | -$10.3M | -33.1% |
| Interest Expense | $3.4M | -12.2% |
| Pre-tax Income | -$12.6M | -1.7% |
| Income Tax | -$183K | — |
| Net Income | -$12.4M | -0.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $207K | +203.9% |
| Accounts Receivable | $2.5M | +8.7% |
| Inventory | $184K | +13.7% |
| Current Assets | $3.1M | +8.0% |
| Total Assets | $44.6M | +6.9% |
| Current Liabilities | $28.7M | -12.4% |
| Total Liabilities | $33.5M | -8.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -36.1% |
| Capital Expenditures | $62K | — |
| Investing Cash Flow | -$656K | -5018.6% |
| Financing Cash Flow | $4.7M | +63.1% |
| Free Cash Flow | -$3.9M | — |
| $11.1M |
| +109.3% |